Inquire Before Buying - Anemia Drugs Market Size, Share, Growth, Trends & Outlook

Global Anemia Drugs Market Research Report: Forecast (2025-2030)

Anemia Drugs Market Size, Value and Forecast - By Anemia Type (Iron Deficiency Anemia, Pernicious Anemia, Aplastic Anemia, Hemolytic Anemia, Sickle Cell Anemia, Thalassemia, Others......), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Others Read more

Healthcare
Aug 2025
Pages 188
Report Format: PDF, Excel, PPT

Market Definition

Anemia is a type of blood disorder which is caused by a deficiency of hemoglobin or red blood cells (RBCs) in the blood of both animals and humans. The symptoms of anemia may include fatigue, decreased focus and concentration, including shortness of breath on any intense physical activity. There are different types of anemia, such as microcytic, normocytic, macrocytic, and dimorphic anemia.

Market Insights & Analysis: Global Anemia Drugs Market (2025-30):

The Global Anemia Drugs Market size was valued at around USD 14.62 billion in 2024 and is projected to reach USD 21.73 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 6.83% during the forecast period, i.e., 2025-30. The main reason behind this growth is the rising anemia affliction and awareness, along with the aging of the population globally. Other factors include poor diet, genetics, underlying illnesses, non-adherence in patients, as well as limited access to healthcare in major regions of the world, such as in Africa and South Asia.

In response, several countries have increased their efforts against anemia, increasing the demand for anemia treatment and benefiting pharmaceutical companies. For instance, in 2023, India expanded its "Anemia Mukt Bharat" initiative by improving the supply chains for iron and folic acid tablets across its rural districts, due to which pharmaceutical companies involved in anemia drugs are now seeing a rise in procurement through public tenders. This demand has also driven activities in related industries, such as active pharmaceutical ingredient (API) production and packaging. For instance, in 2024, Lupin partnered with API suppliers across Southeast Asia to ensure that there was uninterrupted production of its iron-based formulations for anemia treatment programs.

Despite such efforts, anemia continues to affect public health, especially among the vulnerable population. For instance, in 2023, the World Health Organization (WHO) reported that certain demographic groups are disproportionately afflicted, amounting to about 35.5% of pregnant women aged 15–49 years and 39.8% of children under the age of 5, increasing the demand for more effective and accessible drug options in the market. While this causes the world to go off track in achieving a 50% reduction in anemia cases by the end of this decade, it makes way for companies to innovate and expand their portfolios of anemia drugs to meet this growing demand.

Global Anemia Drugs Market Scope:

Category	Segments
By Anemia Type	Iron Deficiency Anemia, Pernicious Anemia, Aplastic Anemia, Hemolytic Anemia, Sickle Cell Anemia, Thalassemia, Others
By Route of Administration	Oral, Injectable
By Distribution Channel	Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Furthermore, public-private partnerships (PPPs) and the involvement of non-governmental organizations (NGOs) play an important role in addressing the global impact of anemia, which is particularly serious in low and middle-income countries (LMICs). For instance, governments globally have collaborated with pharmaceutical companies to improve awareness and promote iron supplementation programs. These joint efforts are often implemented through national health initiatives with an aim to expand access to essential anemia drugs and close treatment gaps among vulnerable populations. As a result, such coordinated actions are driving the demand for effective anemia drugs in these countries.

Global Anemia Drugs Market Driver:

Innovations in Drug Technologies – There have been several innovations in the Global Anemia Drugs Market with the introduction of oral HIF-prolyl hydroxylase inhibitors, such as daprodustat and roxadustat, as alternatives to injectables, offering convenience and accessibility to patients. These oral drugs are particularly beneficial for patients afflicted with chronic kidney disease (CKD), where long-term treatment adherence and convenience become vital. For instance, in 2023, the US Food and Drug Administration (FDA) approved Jesduvroq (daprodustat) as the first once-a-day oral treatment for anemia associated with CKD in adults who are undergoing dialysis for at least four months. The typical treatment before this was approved by the FDA was injected into the bloodstream. Additionally, Roxadustat is another such oral drug for CKD-associated anemia, which was developed by FibroGen in partnership with AstraZeneca. These innovations help in providing patients with more options for anemia treatment, thereby driving demand and creating growth opportunities for pharmaceutical companies that specialize in anemia drugs.

Market Segmentation
Introduction
1. Product Definition
2. Research Process
3. Assumptions
Executive Summary
Global Anemia Drugs Market Regulations, Policies & Standards
Global Anemia Drugs Market Trends & Developments
Global Anemia Drugs Market Dynamics
1. Growth Drivers
2. Challenges
Global Anemia Drugs Market Hotspots & Opportunities
Global Anemia Drugs Market Value Chain Analysis
Global Anemia Drugs Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Anemia Type
    1. Iron Deficiency Anemia – Market Size & Forecast 2020–2030, USD Million
    2. Pernicious Anemia – Market Size & Forecast 2020–2030, USD Million
    3. Aplastic Anemia – Market Size & Forecast 2020–2030, USD Million
    4. Hemolytic Anemia – Market Size & Forecast 2020–2030, USD Million
    5. Sickle Cell Anemia – Market Size & Forecast 2020–2030, USD Million
    6. Thalassemia – Market Size & Forecast 2020–2030, USD Million
    7. Others – Market Size & Forecast 2020–2030, USD Million
  2. By Route of Administration
    1. Oral – Market Size & Forecast 2020–2030, USD Million
    2. Injectable – Market Size & Forecast 2020–2030, USD Million
  3. By Distribution Channel
    1. Hospital Pharmacies – Market Size & Forecast 2020–2030, USD Million
    2. Retail Pharmacies – Market Size & Forecast 2020–2030, USD Million
    3. Online Pharmacies – Market Size & Forecast 2020–2030, USD Million
    4. Others – Market Size & Forecast 2020–2030, USD Million
  4. By Region
    1. North America
    2. South America
    3. Europe
    4. The Middle East & Africa
    5. Asia-Pacific
North America Anemia Drugs Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Anemia Type – Market Size & Forecast 2020–2030, USD Million
  2. By Route of Administration– Market Size & Forecast 2020–2030, USD Million
  3. By Distribution Channel – Market Size & Forecast 2020–2030, USD Million
  4. By Country
    1. The US
    2. Canada
    3. Mexico
3. The US Anemia Drugs Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Anemia Type – Market Size & Forecast 2020–2030, USD Million
    2. By Route of Administration – Market Size & Forecast 2020–2030, USD Million
    3. By Distribution Channel – Market Size & Forecast 2020–2030, USD Million
4. Canada Anemia Drugs Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Anemia Type – Market Size & Forecast 2020–2030, USD Million
    2. By Route of Administration – Market Size & Forecast 2020–2030, USD Million
    3. By Distribution Channel – Market Size & Forecast 2020–2030, USD Million
5. Mexico Anemia Drugs Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Anemia Type – Market Size & Forecast 2020–2030, USD Million
    2. By Route of Administration – Market Size & Forecast 2020–2030, USD Million
    3. By Distribution Channel – Market Size & Forecast 2020–2030, USD Million
South America Anemia Drugs Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Anemia Type – Market Size & Forecast 2020–2030, USD Million
  2. By Route of Administration – Market Size & Forecast 2020–2030, USD Million
  3. By Distribution Channel – Market Size & Forecast 2020–2030, USD Million
  4. By Country
    1. Brazil
    2. Argentina
    3. Rest of South America
3. Brazil Anemia Drugs Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Anemia Type – Market Size & Forecast 2020–2030, USD Million
    2. By Route of Administration – Market Size & Forecast 2020–2030, USD Million
    3. By Distribution Channel – Market Size & Forecast 2020–2030, USD Million
4. Argentina Anemia Drugs Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Anemia Type – Market Size & Forecast 2020–2030, USD Million
    2. By Route of Administration – Market Size & Forecast 2020–2030, USD Million
    3. By Distribution Channel – Market Size & Forecast 2020–2030, USD Million
Europe Anemia Drugs Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Anemia Type – Market Size & Forecast 2020–2030, USD Million
  2. By Route of Administration – Market Size & Forecast 2020–2030, USD Million
  3. By Distribution Channel – Market Size & Forecast 2020–2030, USD Million
  4. By Country
    1. Germany
    2. United Kingdom
    3. France
    4. Italy
    5. Spain
    6. Rest of Europe
3. Germany Anemia Drugs Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Anemia Type – Market Size & Forecast 2020–2030, USD Million
    2. By Route of Administration – Market Size & Forecast 2020–2030, USD Million
    3. By Distribution Channel – Market Size & Forecast 2020–2030, USD Million
4. United Kingdom Anemia Drugs Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Anemia Type – Market Size & Forecast 2020–2030, USD Million
    2. By Route of Administration – Market Size & Forecast 2020–2030, USD Million
    3. By Distribution Channel – Market Size & Forecast 2020–2030, USD Million
5. France Anemia Drugs Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Anemia Type – Market Size & Forecast 2020–2030, USD Million
    2. By Route of Administration – Market Size & Forecast 2020–2030, USD Million
    3. By Distribution Channel – Market Size & Forecast 2020–2030, USD Million
6. Italy Anemia Drugs Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Anemia Type – Market Size & Forecast 2020–2030, USD Million
    2. By Route of Administration – Market Size & Forecast 2020–2030, USD Million
    3. By Distribution Channel – Market Size & Forecast 2020–2030, USD Million
7. Spain Anemia Drugs Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Anemia Type – Market Size & Forecast 2020–2030, USD Million
    2. By Route of Administration – Market Size & Forecast 2020–2030, USD Million
    3. By Distribution Channel – Market Size & Forecast 2020–2030, USD Million
Middle East and Africa Anemia Drugs Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Anemia Type – Market Size & Forecast 2020–2030, USD Million
  2. By Route of Administration – Market Size & Forecast 2020–2030, USD Million
  3. By Distribution Channel – Market Size & Forecast 2020–2030, USD Million
  4. By Country
    1. Saudi Arabia
    2. The UAE
    3. South Africa
    4. Rest of Middle East and Africa
3. Saudi Arabia Anemia Drugs Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Anemia Type – Market Size & Forecast 2020–2030, USD Million
    2. By Route of Administration – Market Size & Forecast 2020–2030, USD Million
    3. By Distribution Channel – Market Size & Forecast 2020–2030, USD Million
4. The UAE Anemia Drugs Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Anemia Type – Market Size & Forecast 2020–2030, USD Million
    2. By Route of Administration – Market Size & Forecast 2020–2030, USD Million
    3. By Distribution Channel – Market Size & Forecast 2020–2030, USD Million
5. South Africa Anemia Drugs Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Anemia Type – Market Size & Forecast 2020–2030, USD Million
    2. By Route of Administration – Market Size & Forecast 2020–2030, USD Million
    3. By Distribution Channel – Market Size & Forecast 2020–2030, USD Million
Asia-Pacific Anemia Drugs Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Anemia Type – Market Size & Forecast 2020–2030, USD Million
  2. By Route of Administration – Market Size & Forecast 2020–2030, USD Million
  3. By Distribution Channel – Market Size & Forecast 2020–2030, USD Million
  4. By Country
    1. China
    2. Japan
    3. India
    4. South Korea
    5. Australia
    6. Rest of Asia-Pacific
3. China Anemia Drugs Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Anemia Type – Market Size & Forecast 2020–2030, USD Million
    2. By Route of Administration – Market Size & Forecast 2020–2030, USD Million
    3. By Distribution Channel – Market Size & Forecast 2020–2030, USD Million
4. Japan Anemia Drugs Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Anemia Type – Market Size & Forecast 2020–2030, USD Million
    2. By Route of Administration – Market Size & Forecast 2020–2030, USD Million
    3. By Distribution Channel – Market Size & Forecast 2020–2030, USD Million
5. India Anemia Drugs Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Anemia Type – Market Size & Forecast 2020–2030, USD Million
    2. By Route of Administration – Market Size & Forecast 2020–2030, USD Million
    3. By Distribution Channel – Market Size & Forecast 2020–2030, USD Million
6. South Korea Anemia Drugs Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Anemia Type – Market Size & Forecast 2020–2030, USD Million
    2. By Route of Administration – Market Size & Forecast 2020–2030, USD Million
    3. By Distribution Channel – Market Size & Forecast 2020–2030, USD Million
7. Australia Anemia Drugs Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Anemia Type – Market Size & Forecast 2020–2030, USD Million
    2. By Route of Administration – Market Size & Forecast 2020–2030, USD Million
    3. By Distribution Channel – Market Size & Forecast 2020–2030, USD Million
Global Anemia Drugs Market Strategic Imperatives for Growth & Success
Competition Outlook
1. Company Profiles
  1. Amgen Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  2. Pfizer Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  3. GlaxoSmithKline plc
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  4. Biocon Ltd.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  5. Bluebird bio, Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  6. Eli Lilly and Company
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  7. Johnson & Johnson Services, Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  8. Bayer AG
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  9. GlycoMimetics, Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  10. Regen Biopharma Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  11. Acceleron Pharma
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  12. F. Hoffmann-La Roche Ltd.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  13. Novartis AG
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  14. Zydus Lifesciences Ltd.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  15. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO INQUIRE BEFORE BUYING THIS REPORT

Name *

Email ID *

Country *